Hyderabad: Bharat Biotech International Ltd has announced the formal launch of Nucelion Therapeutics Pvt Ltd, marking its ...

The company has $400 million, enough cash to potentially build off results from an early-stage leukemia yet this quarter.

Samsung Biologics Co., the biotech arm of Samsung Group, said Tuesday it has secured contract manufacturing deals worth more ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

Novo Nordisk made a much higher offer to acquire a biotech Pfizer was already set to buy out. Losing this battle would be more damaging to Pfizer than to Novo Nordisk. Even so, both companies look ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

These healthcare stocks are making strides in very important ways. The healthcare industry revolves around constant innovation in areas like biotechnology, pharmaceuticals, medical devices, and ...

Krystal Biotech Inc. advanced stock charts by Barron's. View KRYS historical stock data and compare to other stocks, and exchanges.

Vertex Pharmaceuticals (VRTX) is rapidly closing the market capitalization gap with pharmaceutical behemoth Pfizer (PFE), leveraging a robust growth trajectory and a diversified pipeline that ...